Description
The Department of Veterans Affairs is conducting market research to identify potential sources capable of providing genomic profile testing for thyroid cancer. The testing is intended to support clinical decision-making by identifying genetic mutations and molecular markers associated with thyroid malignancies. The VA is seeking vendors capable of providing a comprehensive genomic profiling test for thyroid cancer that includes detection of gene mutations, fusions, and expression profiles relevant to thyroid cancer, ability to distinguish between benign and malignant thyroid nodules, CLIA-certified and CAP-accredited laboratory testing, and electronic reporting of results with interpretation.
• Detection of gene mutations, fusions, and expression profiles relevant to thyroid cancer
• Ability to distinguish between benign and malignant thyroid nodules
• CLIA-certified and CAP-accredited laboratory testing
• Turnaround time of ≤14 calendar days from sample receipt
• Electronic reporting of results with interpretation
• Specimen collection kits and shipping logistics support
• HIPAA-compliant data handling and reporting